Cargando…
How Do mAbs Make Use of Complement to Kill Cancer Cells? The Role of Ca(2+)
We examined the kinetics and mechanisms by which monoclonal antibodies (mAbs) utilize complement to rapidly kill targeted cancer cells. Based on results from flow cytometry, confocal microscopy and high-resolution digital imaging experiments, the general patterns which have emerged reveal cytotoxic...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551823/ https://www.ncbi.nlm.nih.gov/pubmed/32899722 http://dx.doi.org/10.3390/antib9030045 |